Oh, Ozempic: Retail analysts see little impact from weight-l

Pharmaceutical advocates have hyped the success of high-priced, weight-loss drugs like Ozempic in a campaign to make appetite-suppressing medications a new standard of obesity care, retail analysts say.

Related Keywords

Texas , United States , Washington , Denmark , Danish , Americans , Branden Muhl , Los Angeles , Markus Bjoerkheim , Andy Puzder , Natalie Bello , Jessica Thompson , Adolfo Cuevas , Larry Lavine , Allison Schneider , Eli Lilly , Walmart , Centers For Medicare Medicaid Services , Mahaska Bottling Co , Heritage Foundation , Department Of Health , Mercatus Center , Drug Administration , Carl Jr , George Mason University , Eli Lilly Co , Human Services , Kroger , Sinai Medical Center , Hardee , Public Health At New York University , Novo Nordisk , Conagra Brands , Washington Times , Beyond Meat , Reduce Obesity Act , Medicaid Services , Social Security , Mahaska Markets , Cedars Sinai Medical Center , Social Justice , Public Health , New York ,